Filter your results
- 4
- 3
- 1
- 4
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL PatientsMediators of Inflammation, 2017, pp.7960907, 2017, ⟨10.1155/2017/7960907⟩
Special issue
inserm-03841057v1
|
||
|
Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.Journal of Hematology and Oncology, 2010, 3 (1), pp.30. ⟨10.1186/1756-8722-3-30⟩
Journal articles
inserm-00668207v1
|
||
|
Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.Haematologica, 2011, 96 (6), pp.927-31. ⟨10.3324/haematol.2010.037689⟩
Journal articles
inserm-00741102v1
|
||
|
BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.Modern Pathology, 2012, 25 (6), pp.805-14. ⟨10.1038/modpathol.2012.1⟩
Journal articles
inserm-00682931v1
|